# Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol

> **NCT00740259** · PHASE4 · COMPLETED · sponsor: **Ambulatório de Bipolaridade** · enrollment: 70 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Flunarizine

## Key facts

- **NCT ID:** NCT00740259
- **Lead sponsor:** Ambulatório de Bipolaridade
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2008-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740259, "Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00740259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*